Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Canet

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Brain : a Journal of Neurology|November 21, 2024
Proteostasis restoration: a new metric for tau immunotherapy efficacyGeoffrey Canet, Emmanuel Planel
Journal of Alzheimer'S Disease : JAD|March 18, 2026
Lifelong heat exposure as a potential contributor to Alzheimer's disease resilienceGeoffrey Canet, Brendan P Lucey, Esther M Blessing, et al.
Frontiers in Neuroscience|November 22, 2018
Central Role of Glucocorticoid Receptors in Alzheimer's Disease and DepressionGeoffrey Canet, Nathalie Chevallier, Charleine Zussy, et al.
Frontiers in Aging Neuroscience|October 16, 2019
Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic TargetsGeoffrey Canet, Célia Hernandez, Charleine Zussy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMark Stephen Williams, Sofia Diego-Diaz, Geoffrey Canet, et al.
Pharmacology & Therapeutics|March 31, 2023
The pathomimetic oAβ<sub>25</sub><sub>-</sub><sub>35</sub> model of Alzheimer's disease: Potential for screening of new therapeutic agentsGeoffrey Canet, Charleine Zussy, Célia Hernandez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisGeoffrey Canet, Nicolas Sergeant, Brendan P Lucey, et al.
Neuroendocrinology|December 19, 2021
Chronic Glucocorticoids Consumption Triggers and Worsens Experimental Alzheimer's Disease-Like Pathology by Detrimental Immune ModulationsGeoffrey Canet, Charleine Zussy, Célia Hernandez, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Methods for Biochemical Isolation of Insoluble Tau in Rodent Models of TauopathiesGeoffrey Canet, Emma Rocaboy, Sofia Diego-Diàz, et al.
Neurobiology of Aging|July 28, 2016
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicityFanny Pineau, Geoffrey Canet, Catherine Desrumaux, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Brain : a Journal of Neurology|November 21, 2024
Proteostasis restoration: a new metric for tau immunotherapy efficacyGeoffrey Canet, Emmanuel Planel
Journal of Alzheimer'S Disease : JAD|March 18, 2026
Lifelong heat exposure as a potential contributor to Alzheimer's disease resilienceGeoffrey Canet, Brendan P Lucey, Esther M Blessing, et al.
Frontiers in Neuroscience|November 22, 2018
Central Role of Glucocorticoid Receptors in Alzheimer's Disease and DepressionGeoffrey Canet, Nathalie Chevallier, Charleine Zussy, et al.
Frontiers in Aging Neuroscience|October 16, 2019
Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic TargetsGeoffrey Canet, Célia Hernandez, Charleine Zussy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMark Stephen Williams, Sofia Diego-Diaz, Geoffrey Canet, et al.
Pharmacology & Therapeutics|March 31, 2023
The pathomimetic oAβ<sub>25</sub><sub>-</sub><sub>35</sub> model of Alzheimer's disease: Potential for screening of new therapeutic agentsGeoffrey Canet, Charleine Zussy, Célia Hernandez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisGeoffrey Canet, Nicolas Sergeant, Brendan P Lucey, et al.
Neuroendocrinology|December 19, 2021
Chronic Glucocorticoids Consumption Triggers and Worsens Experimental Alzheimer's Disease-Like Pathology by Detrimental Immune ModulationsGeoffrey Canet, Charleine Zussy, Célia Hernandez, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Methods for Biochemical Isolation of Insoluble Tau in Rodent Models of TauopathiesGeoffrey Canet, Emma Rocaboy, Sofia Diego-Diàz, et al.
Neurobiology of Aging|July 28, 2016
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicityFanny Pineau, Geoffrey Canet, Catherine Desrumaux, et al.
Pageof 3